Differentially expressed miRNAs (p value<0.05) in B cells from patients with pSS compared with the controls in the discovery cohort (two different normalisation ways were used: global mean and reference miRNAs)
(pSS BL) vs (ctrl BL)/global mean normalisation | (pSS BL) vs (ctrl BL)/reference miRNAs normalisation | Common miRNAs/global mean and reference miRNAs | ||||
miRNAs | Fold change | p Value | miRNAs | Fold change | p Value | |
hsa-miR-30b-5p | −1.52 | 4.08E-04 | hsa-miR-30b-5p | −1.56 | 5.01E-03 | hsa-miR-30b-5p |
hsa-miR-222–3 p | 1.46 | 4.16E-04 | hsa-miR-222–3 p | 1.43 | 2.29E-04 | hsa-miR-222–3 p |
hsa-miR-107 | 1.35 | 1.07E-03 | hsa-miR-107 | 1.32 | 2.35E-03 | hsa-miR-107 |
hsa-miR-18a-3p | 1.94 | 1.79E-03 | hsa-miR-18a-3p | 1.89 | 3.51E-03 | hsa-miR-18a-3p |
hsa-miR-324–5 p | 1.64 | 1.81E-03 | hsa-miR-324–5 p | 1.6 | 2.60E-03 | hsa-miR-324–5 p |
hsa-miR-151a-3p | 1.4 | 1.96E-03 | hsa-miR-151a-3p | 1.37 | 4.71E-03 | hsa-miR-151a-3p |
hsa-miR-324–3 p | 1.22 | 2.21E-03 | hsa-miR-324–3 p | 1.19 | 0.026 | hsa-miR-324–3 p |
hsa-miR-19b-3p | −1.39 | 3.35E-03 | hsa-miR-19b-3p | −1.43 | 0.014 | hsa-miR-19b-3p |
hsa-miR-26a-5p | −1.34 | 5.38E-03 | hsa-miR-26a-5p | −1.37 | 0.016 | hsa-miR-26a-5p |
hsa-miR-20a-5p | −1.17 | 5.81E-03 | hsa-miR-20a-5p | −1.2 | 0.014 | hsa-miR-20a-5p |
hsa-miR-141–3 p | −1.86 | 6.54E-03 | hsa-miR-141–3 p | −1.9 | 5.64E-03 | hsa-miR-141–3 p |
hsa-miR-29b-2–5 p | 1.39 | 7.51E-03 | hsa-miR-29b-2–5 p | 1.35 | 0.010 | hsa-miR-29b-2–5 p |
hsa-miR-374a-5p | −1.54 | 8.90E-03 | hsa-miR-374a-5p | −1.58 | 0.017 | hsa-miR-374a-5p |
hsa-miR-484 | 1.45 | 0.012 | hsa-miR-484 | 1.41 | 0.019 | hsa-miR-484 |
hsa-miR-195–5 p | −1.57 | 0.012 | hsa-miR-195–5 p | −1.61 | 0.019 | hsa-miR-195–5 p |
hsa-miR-210 | 1.33 | 0.012 | hsa-miR-210 | 1.3 | 0.039 | hsa-miR-210 |
hsa-miR-32–5 p | −1.63 | 0.013 | hsa-miR-32–5 p | −1.67 | 0.027 | hsa-miR-32–5 p |
hsa-miR-582–5 p | −1.67 | 0.014 | hsa-miR-582–5 p | −1.72 | 0.018 | hsa-miR-582–5 p |
hsa-let-7d-3p | −1.65 | 0.022 | hsa-let-7d-3p | −1.7 | 8.83E-03 | hsa-let-7d-3p |
hsa-miR-378a-3p | −1.35 | 0.027 | hsa-miR-378a-3p | −1.38 | 0.020 | hsa-miR-378a-3p |
hsa-miR-505–3 p | −1.59 | 0.027 | hsa-miR-505–3 p | −1.63 | 0.020 | hsa-miR-505–3 p |
hsa-miR-30c-5p | −1.17 | 0.028 | ||||
hsa-miR-491–5 p | 1.57 | 0.029 | hsa-miR-491–5 p | 1.53 | 0.036 | hsa-miR-491–5 p |
hsa-miR-502–5 p | 1.74 | 0.029 | hsa-miR-502–5 p | 1.69 | 0.048 | hsa-miR-502–5 p |
hsa-miR-151a-5p | 1.2 | 0.035 | ||||
hsa-miR-148b-3p | −1.23 | 0.038 | hsa-miR-148b-3p | −1.26 | 0.012 | hsa-miR-148b-3p |
hsa-miR-130b-3p | 1.47 | 0.041 | ||||
hsa-miR-15a-5p | −1.21 | 0.043 | ||||
hsa-miR-29b-3p | −1.48 | 0.044 | ||||
hsa-miR-296–5 p | 1.64 | 0.044 | ||||
hsa-miR-142–5 p | −1.53 | 0.046 | ||||
hsa-miR-192–5 p | −1.28 | 0.048 | ||||
hsa-miR-374b-5p | −1.38 | 0.049 |
‘MiRNAs in grey’ represents those found differentially expressed by one way of normalisation only. Nominal p-values without correction for multiple comparisons are shown.
BL, B lymphocytes; miRNA, microRNA; pSS, primary Sjögren’s syndrome.